Benjamin S. Daniel

1.5k total citations
37 papers, 589 citations indexed

About

Benjamin S. Daniel is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Benjamin S. Daniel has authored 37 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 16 papers in Dermatology and 16 papers in Rheumatology. Recurrent topics in Benjamin S. Daniel's work include Autoimmune Bullous Skin Diseases (16 papers), Urticaria and Related Conditions (12 papers) and Dermatology and Skin Diseases (8 papers). Benjamin S. Daniel is often cited by papers focused on Autoimmune Bullous Skin Diseases (16 papers), Urticaria and Related Conditions (12 papers) and Dermatology and Skin Diseases (8 papers). Benjamin S. Daniel collaborates with scholars based in Australia, United States and United Kingdom. Benjamin S. Daniel's co-authors include Dédée F. Murrell, David Orchard, Supriya S. Venugopal, Rüdiger Eming, Victoria P. Werth, Michael Hertl, John Su, Linda K. Martin, John W. Frew and Cathy Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Benjamin S. Daniel

33 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin S. Daniel Australia 14 313 215 186 181 117 37 589
Marwah Adly Saleh Egypt 14 255 0.8× 176 0.8× 189 1.0× 106 0.6× 135 1.2× 40 506
Savaş Yaylı Türkiye 12 439 1.4× 357 1.7× 303 1.6× 169 0.9× 57 0.5× 50 748
C. S. Seitz Germany 10 162 0.5× 161 0.7× 118 0.6× 75 0.4× 78 0.7× 22 599
Rana Abdat United States 6 124 0.4× 122 0.6× 80 0.4× 139 0.8× 100 0.9× 9 376
Toshikazu Usuda Japan 9 250 0.8× 224 1.0× 104 0.6× 98 0.5× 39 0.3× 22 447
F Chrysomallis Greece 11 281 0.9× 189 0.9× 125 0.7× 107 0.6× 26 0.2× 16 424
Zahra Hallaji Iran 19 562 1.8× 350 1.6× 350 1.9× 247 1.4× 98 0.8× 36 954
David L. Cram United States 16 326 1.0× 179 0.8× 107 0.6× 277 1.5× 127 1.1× 28 784
İlkin Zindancı Türkiye 11 144 0.5× 149 0.7× 67 0.4× 143 0.8× 22 0.2× 55 418
A. KOBZA-BLACK United Kingdom 13 227 0.7× 517 2.4× 239 1.3× 178 1.0× 16 0.1× 19 714

Countries citing papers authored by Benjamin S. Daniel

Since Specialization
Citations

This map shows the geographic impact of Benjamin S. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin S. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin S. Daniel more than expected).

Fields of papers citing papers by Benjamin S. Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin S. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin S. Daniel. The network helps show where Benjamin S. Daniel may publish in the future.

Co-authorship network of co-authors of Benjamin S. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin S. Daniel. A scholar is included among the top collaborators of Benjamin S. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin S. Daniel. Benjamin S. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akbarialiabad, Hossein, et al.. (2025). Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo. JEADV Clinical Practice. 4(5). 1140–1145.
2.
Foley, Peter, et al.. (2025). Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant Disease. Australasian Journal of Dermatology. 66(3). 169–171. 1 indexed citations
3.
Daniel, Benjamin S., et al.. (2024). A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo. Australasian Journal of Dermatology. 65(7). 539–549. 1 indexed citations
4.
Daniel, Benjamin S., et al.. (2023). A review of JAK and IL‐23 inhibitors to treat vitiligo. Australasian Journal of Dermatology. 64(2). 204–212. 6 indexed citations
5.
Wu, Duoduo, Benjamin S. Daniel, Abbie Lai, et al.. (2022). Dupilumab-associated ocular manifestations: A review of clinical presentations and management. Survey of Ophthalmology. 67(5). 1419–1442. 20 indexed citations
6.
Daniel, Benjamin S., et al.. (2021). Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital. Australasian Journal of Dermatology. 62(3). 427–428. 2 indexed citations
7.
8.
Daniel, Benjamin S. & Dédée F. Murrell. (2020). The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 setting. International Journal of Women’s Dermatology. 7(2). 228–229. 2 indexed citations
9.
Daniel, Benjamin S.. (2020). The multiple comorbidities of psoriasis: The importance of a holistic approach. Australian Journal of General Practice. 49(7). 433–437. 4 indexed citations
10.
Daniel, Benjamin S., et al.. (2019). Cutaneous lupus erythematosus: A review of the literature. International Journal of Women’s Dermatology. 5(5). 320–329. 26 indexed citations
11.
Rodrigues, Michelle, et al.. (2016). Australian dermatologists’ perspective on skin of colour: Results of a national survey. Australasian Journal of Dermatology. 59(1). e23–e30. 18 indexed citations
12.
Hwang, Shelley Ji Eun, et al.. (2015). Prevalence of anemia in patients with epidermolysis bullosa registered in Australia. SHILAP Revista de lepidopterología. 1(1). 37–40. 21 indexed citations
13.
Daniel, Benjamin S. & Dédée F. Murrell. (2014). Management of pemphigus. F1000Prime Reports. 6. 32–32. 4 indexed citations
14.
Sebaratnam, Deshan F., John W. Frew, Supriya S. Venugopal, et al.. (2013). Development of a Quality-of-Life Instrument for Autoimmune Bullous Disease. JAMA Dermatology. 149(10). 1186–1186. 59 indexed citations
15.
Daniel, Benjamin S., John W. Frew, Deshan F. Sebaratnam, et al.. (2013). The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. British Journal of Dermatology. 169(5). 1000–1006. 51 indexed citations
16.
Kim, Jaehwan, John Su, Benjamin S. Daniel, et al.. (2013). Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI). Journal of the American Academy of Dermatology. 70(1). 89–97.e13. 39 indexed citations
17.
Daniel, Benjamin S., Dédée F. Murrell, & P. Joly. (2012). Rituximab and its Use in Autoimmune Bullous Disorders. Immunology and Allergy Clinics of North America. 32(2). 331–337. 1 indexed citations
18.
Daniel, Benjamin S., Michael Hertl, Victoria P. Werth, Rüdiger Eming, & Dédée F. Murrell. (2011). Severity score indexes for blistering diseases. Clinics in Dermatology. 30(1). 108–113. 77 indexed citations
19.
Daniel, Benjamin S., Luca Borradori, Russell P. Hall, & Dédée F. Murrell. (2011). Evidence-Based Management of Bullous Pemphigoid. Dermatologic Clinics. 29(4). 613–620. 19 indexed citations
20.
Daniel, Benjamin S. & Dédée F. Murrell. (2010). The actual management of pemphigus.. PubMed. 145(5). 689–702. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marwah Adly Saleh Breakdown of academic impact, for papers by Savaş Yaylı Breakdown of academic impact, for papers by C. S. Seitz Breakdown of academic impact, for papers by Rana Abdat Breakdown of academic impact, for papers by Toshikazu Usuda Breakdown of academic impact, for papers by F Chrysomallis Breakdown of academic impact, for papers by Zahra Hallaji Breakdown of academic impact, for papers by David L. Cram Breakdown of academic impact, for papers by İlkin Zindancı Breakdown of academic impact, for papers by A. KOBZA-BLACK
Rankless by CCL
2026